Cardinal Health
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Cardinal Health (CAH) Business News
Track Cardinal Health in real time with a live news feed covering Cardinal Health stock news, official press releases, company announcements, and an archive of historical Cardinal Health news. ...more
- Learn more about Cardinal Health’s Revenue, CEO Salary, Employees, Revenue by Segment and Ownership.
- Check out competitors to Cardinal Health in a side-by-side comparison.
- Explore additional financials, or market metrics (e.g., Market cap, PE ratio, Dividend).
- Access Company Filings & Reports for the latest updates.
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Loading news...
Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
4,000 Shares in Cardinal Health, Inc. $CAH Purchased by FNY Investment Advisers LLC
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
Burns Matteson Capital Management LLC Boosts Holdings in Cardinal Health, Inc. $CAH
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
Loading more...
Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings
7:00 AM | Tuesday | Apr 14, 2026
Research confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes. DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care.
Read full articleNo data available for this time period.
Change the time range to see results.
Cardinal Health report highlights growing momentum to expand advanced therapies into community care settings
PRNewsWireResearch confirms advanced therapies are moving beyond inpatient hospitals, with providers increasingly supporting partnerships that bring life-changing treatments closer to patients' homes. DUBLIN, Ohio, April 14, 2026 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its 2026 Advanced Therapies Report: Perspectives on Community Expansion, offering new insights into how the expanding advanced therapy pipeline is reshaping sites of care.
Read full article
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
Zacks Investment ResearchCAH's specialty growth, strong pharma demand and expanding services portfolio are driving earnings momentum and positioning it for sustained long-term growth.
Read full article
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Zacks Investment ResearchHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read full article
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Zacks Investment ResearchWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read full article
4,000 Shares in Cardinal Health, Inc. $CAH Purchased by FNY Investment Advisers LLC
Defense WorldFNY Investment Advisers LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE: CAH) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund bought 4,000 shares of the company's stock, valued at approximately $822,000. Other hedge funds have also made changes to
Read full article
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies
Zacks Investment ResearchCAH expands Ac-225 capacity, boosting its role in radiopharma as rising clinical demand and future cancer therapy commercialization drive growth.
Read full article
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth?
Zacks Investment ResearchCAH's specialty flywheel strategy links distribution, MSOs and biopharma services, boosting partnerships, drug launches and recurring revenue potential.
Read full article
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
PRNewsWireDUBLIN, Ohio, April 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced a significant expansion of its Actinium-225 (Ac-225) production capabilities at the company's Center for Theranostics Advancement (CTA) in Indianapolis, Indiana. The addition of a high-capacity production line to its Drug Master File (DMF) will substantially increase Cardinal Health's supply of cGMP-compliant Ac-225 for use in investigational therapeutic drug products and future commercial manufacturing novel therapies.
Read full article
Burns Matteson Capital Management LLC Boosts Holdings in Cardinal Health, Inc. $CAH
Defense WorldBurns Matteson Capital Management LLC lifted its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 182.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,403 shares of the company's stock after buying an additional 3,492 shares during the period.
Read full article
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
Zacks Investment ResearchIn the latest trading session, Cardinal Health (CAH) closed at $211.31, marking a +2.42% move from the previous day.
Read full article
No data available for this time period.
Change the time range to see results.





